Your session is about to expire
← Back to Search
Behavioral Intervention
Combined Therapies for Maternal PTSD (SMSC Trial)
N/A
Recruiting
Led By Michael A Lindsey
Research Sponsored by New York University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Being able to read, write, and speak English or Spanish
Meeting DSM-5 diagnostic criteria for PTSD (CAPS-5) with or without co-occurring depression (SCID-5)
Must not have
Having a disability affecting communication, such as deafness
Having current symptoms or diagnosis of psychosis as defined by the DSM-5 in the past year (SCID-5)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline (pre-treatment) to mid-treatment at session 9 and 16 to upon completion of treatment (an average of 43 weeks) to six-month follow-up after treatment completion
Awards & highlights
No Placebo-Only Group
Summary
This trial tests a program that helps mothers with PTSD learn to manage their emotions and improve their interactions with their children. It aims to reduce stress and improve family dynamics for mothers receiving family preservation services.
Who is the study for?
This trial is for mothers with PTSD, possibly also depression, who can communicate in English or Spanish and have a child aged 1-8. They must be receiving preventive services, have custody of their child, and meet specific criteria for PTSD severity. Those with recent suicidal thoughts or attempts, psychosis symptoms or diagnosis, substance abuse issues, communication disabilities like deafness, children with developmental conditions impeding function (e.g., autism), or current/recent intimate partner violence are excluded.
What is being tested?
The 'Safe Mothers, Safe Children Initiative' tests the effectiveness of P-STAIR—a combination of Skills Training in Affective and Interpersonal Regulation (STAIR) and Parent-Child Interaction Therapy (PCIT)—in treating maternal PTSD and preventing child maltreatment recurrence.
What are the potential side effects?
While not explicitly stated here, interventions like P-STAIR may lead to emotional discomfort due to discussing traumatic experiences during therapy sessions. There might also be temporary increases in distress as new coping strategies are learned.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I can read, write, and speak in English or Spanish.
Select...
I have been diagnosed with PTSD, with or without depression.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have a disability that affects my ability to communicate.
Select...
I have been diagnosed with or shown symptoms of psychosis in the last year.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ follow-up after treatment completion (six-months after end of treatment)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~follow-up after treatment completion (six-months after end of treatment)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Center for Epidemiological Studies-Depression (CES-D)
Dyadic Parent-Child Interaction Coding System-IV (DPICS)
Family Preservation Services Usual Care (FPSUC) reports
+3 moreSecondary study objectives
Adult Adolescent Parenting Inventory-2.1 (AAPI-2.1)
Difficulties in Emotion Regulation Scale (DERS)
Strengths and Difficulties Questionnaire (SDQ)
+3 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: P-STAIRExperimental Treatment1 Intervention
Participants will receive 23 weekly individual treatment sessions. Each session will last one hour. P-STAIR is a combination of STAIR and PCIT. STAIR focuses on reduction of PTSD symptoms through enhancement of emotion regulation skills. PCIT focuses on the reduction of negative parenting skills and the increase of positive parenting skills.
Group II: Supportive CounselingActive Control1 Intervention
Participants will receive 23 weekly individual treatment sessions. Each session will last one hour. Supportive counseling has been modified to permit non-trauma discussion of parenting problems. Each session is client-directed and clinicians take an unconditionally supportive role.
Find a Location
Who is running the clinical trial?
New York UniversityLead Sponsor
242 Previous Clinical Trials
220,005 Total Patients Enrolled
Michael A LindseyPrincipal InvestigatorNew York University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a child between 1 and 8 years old.Your child has been diagnosed with or has shown symptoms of psychosis in the past three months.I am currently receiving preventive health services.I have a disability that affects my ability to communicate.I can read, write, and speak in English or Spanish.I have been diagnosed with or shown symptoms of psychosis in the last year.You have had thoughts about hurting yourself or have attempted suicide within the past year.You have a child with a developmental condition that affects their thinking or physical abilities, like autism.I have been diagnosed with PTSD, with or without depression.I have a history of intimate or family violence but have been safe for the required time.You have a high score on a test that measures the severity of your symptoms, or you meet the diagnostic criteria for post-traumatic stress disorder (PTSD) according to the latest guidelines.
Research Study Groups:
This trial has the following groups:- Group 1: P-STAIR
- Group 2: Supportive Counseling
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.